New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

LEAD events round-up July 2017 (22 Aug 2017)

July was a busy month for the LEAD Programme. We hosted four events reaching out to different target audiences in General Practice.  An Essential Survival Kit for new GPs was...
Read more »

How to respond to school sickness absence requests (22 Aug 2017)

Dr Elliott Singer, Medical Director lead for our GP State of Emergency campaign, explains how to push back against requests for school sickness absence letters in order to free up...
Read more »

Why the GP Patient Survey matters (22 Aug 2017)

Dr Julie Sharman, Medical Director with our GP and Practice Support Team, explains why practices should care about the GP Patient Survey and what actions they should take to follow-up...
Read more »

Data security and the General Data Protection Regulations (GDPR) - get ready now! (22 Aug 2017)

Earlier this month that the Government announced that the forthcoming European privacy rules set out in the General Data Protection Regulation (GDPR) will come into British law and update the...
Read more »

Extended hours DES and cyber attack (21 Aug 2017)

Following the cyber-attack on NHS computer systems in May a number of practices nationally were told by commissioners that they needed to make up the opening hours lost during the...
Read more »

Waiting room video – what to do when you are referred to a specialist (21 Aug 2017)

Our new waiting room video is designed to inform patients what they can expect when they are referred to a specialist or therapist. The video includes information on tests and...
Read more »

NHS England asking practices to complete its records on possible patient harm due to correspondence lost by Shared Business Services. (21 Aug 2017)

NHS England are say 30% of practices in England have yet to respond to their request to provide details of whether any patients may have come to harm due to...
Read more »

CQC registration fees reimbursement scheme claim process (20 Jul 2017)

The GMS contract changes for 2017/18 includes full reimbursement of Care Quality Commission (CQC) registration fees. This change is being implemented via the Statement of Financial Entitlements (SFE) which means...
Read more »
Next Page »
« Previous Page